Protagonist Therapeutics, Inc — Director's Dealing 2019

Mar 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2019-02-28

Reporting Person: PATEL DINESH V PH D (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-28	Common Stock	A	28750	$0.00	Acquired	386014	Direct
2019-03-01	Common Stock	S	2183	$8.03	Disposed	383831	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Stock Option (right to buy)	$8.02	A	172500	Acquired	2029-02-27	Common Stock (172500)	Direct

Footnotes

F1: Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date.

F2: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F3: The stock option vests in 48 equal monthly installments following the date of grant.